Dachille Douglas A. (CIK 1652908) reported 4 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-06-24). Recent activity: Buy BBIO (3,990 shares), Buy EQH (4,400 shares), Buy BBIO (6,589 shares), Buy EQH (3,393 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-24 | BridgeBio Pharma, Inc. (BBIO) | Director | Buy | 3,990 | $0 |
| 2026-05-21 | Equitable Holdings, Inc. (EQH) | Director | Buy | 4,400 | $185,020 |
| 2025-06-24 | BridgeBio Pharma, Inc. (BBIO) | Director | Buy | 6,589 | $0 |
| 2025-05-23 | Equitable Holdings, Inc. (EQH) | Director | Buy | 3,393 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-06-24